CACarmen Alba-Linero

Carmen Alba-Linero

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Carmen Alba-Linero has a total of 118 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Alergia ocular y enfermedad del ojo seco

    by Carmen Alba Linero, Ibon Eguiluz-Gracia, Carlos Rocha-De-Lossada, José Manuel Benítez del Castillo

    The aim of this narrative review was to examine the clinical and pathophysiologic overlap between dry eye disease (DED) and ocular allergy (OA) and to update their diagnostic and therapeutic approach. The literature indexed in PubMed/MEDLINE through July 2026 was reviewed, prioritizing consensus documents, guidelines, reviews, and relevant clinical studies. Although DED and OA are distinct disorders, they share inflammation, epithelial barrier dysfunction, mucin abnormalities, and loss of tear-film homeostasis. Intense itching favors OA, whereas burning, foreign-body sensation, and fluctuating vision are more characteristic of DED; however, both conditions may coexist. DED diagnosis requires compatible symptoms and objective evidence of homeostatic loss, whereas allergy testing must be interpreted in the context of the clinical history. Conjunctival allergen challenge is reserved for selected cases and should not be performed in the presence of significant ocular inflammation or active sicca disease. Confocal microscopy, cytology, and tear biomarkers remain complementary tools, mainly for research. Treatment should control allergic inflammation without worsening the ocular surface, prioritize preservative-free formulations, and address the underlying drivers of DED. The relationship between both conditions is bidirectional; therefore, an integrated, stepwise approach coordinated between ophthalmology and allergology may interrupt the inflammatory vicious circle and support individualized treatment.

  • Open Access

    Impact of Vascular Risk Factors on Longitudinal Changes in Diabetic Macular Edema After Intravitreal Therapy

    by Carmen Alba-Linero, José Coín Ruiz, Marta Mérida Luque, Javier Espíldora-Hernández, Mario Gutiérrez Bedmar

    Objectives: The aim of this study was to analyze the association between cardiovascular risk factors such as glycated hemoglobin (HbA1c), low-density lipoprotein cholesterol (LDL-C), hypertension, overweight, and smoking and longitudinal anatomical and functional changes in diabetic macular edema (DME) during intravitreal therapy. Materials and Methods: This is a retrospective, observational, descriptive study conducted on a sample of 318 patients with DME associated with some degree of diabetic retinopathy (DR). They were treated with aflibercept, ranibizumab, and/or dexamethasone, assessing anatomical and functional outcomes through visual acuity, retinal thickness, and macular volume. Simultaneously, serum HbA1c and LDL-C levels, blood pressure, body mass index (BMI) and tobacco use were measured at baseline, 6, and 12 months to determine their association with treatment response using linear mixed models. Results: Of the variables analyzed in this study, HbA1c and degree of retinopathy were significantly associated with greater retinal thickness over time. Likewise, we found that, compared with aflibercept, dexamethasone intravitreal treatment was associated with greater retinal thickness over time. Concerning visual acuity, we found an inverse relationship with age, tobacco use and degree of retinopathy. Associations between outcomes and the initial intravitreal agent were observed; however, these findings should be interpreted cautiously. Conclusions: This study was consistent with previous research suggesting an association between glycemic control and DME response and progression. It also highlighted the importance of degree of retinopathy and intravitreal treatment in diabetic macular edema progression. Treatment-related findings represent exploratory associations and should not be interpreted as evidence of comparative effectiveness.

  • Open Access

    Iberian Registry of Ocular Syphilis (IBERSOS) report 1: epidemiology, clinical spectrum and treatment outcomes of ocular syphilis in the Iberian Peninsula

    by Marta Vicente-Antolín, Julio José González-López, Nieves Pardiñas Baron, Guillem Policarpo-Torres, Inés Hernanz, Juan Luis Sánchez Sevila, Amanda García Tirado, Ester Carreño, Maria Jerez Fidalgo, Víctor Llorenç, et al.

    Purpose The Iberian Registry of Ocular Syphilis aims to describe the epidemiology, clinical manifestations and treatment outcomes of ocular syphilis in Spain and Portugal. This re-emerging condition, associated with rising global syphilis rates and HIV coinfection, presents with diverse ocular and systemic features. The study seeks to fill knowledge gaps regarding incidence, presentation and therapeutic response. Methods This multicentre, observational cohort study includes patients aged ≥18 years with newly diagnosed ocular syphilis confirmed by treponemal and nontreponemal serological tests. Conducted across 23 centres, data collection followed routine clinical practice and included demographics, ocular/systemic findings, treatment regimens and outcomes at 3–6 months post-treatment. Results In the first year, 41 patients met the inclusion criteria, of whom 39 consented to participate in the registry, with an incidence of 0.57 cases per 100 000 persons/year. Most were male (94.9%), especially men who have sex with men (66.7%) and HIV coinfection (20.5%). Bilateral ocular involvement was observed in 64.1% of patients, with anterior segment inflammation in 64.1%, vitritis in 53.8%, retinal or choroidal involvement in 69.2% and optic nerve involvement in 59.0%. Systemic syphilis stage included primary (7.7%), secondary (25.6%) and tertiary or quaternary (15.4%). Treatment was initiated after a mean of 6.2±9.3 weeks after the onset of symptoms, and 2.6±6.0 weeks after the initial presentation at the hospital. Intravenous penicillin G was used in 65.8%, and 61.3% achieved a four-fold titre reduction in the reaginic test at the final visit (3 to 6 months after antibiotic therapy). Final visual acuity improved to 0.17 LogMAR (pConclusions Ocular syphilis in the Iberian Peninsula shows a wide clinical spectrum and frequent posterior segment involvement. Most patients achieved favourable serological and visual outcomes. These findings support the effectiveness of standard therapies and highlight the need for early diagnosis, especially in high-risk populations.


  • Retinal structure and vasculature changes and their relationship with mild cognitive impairment in type 2 diabetes

    by Facundo Urbinati, José Antonio Reyes Bueno, Paloma Spínola Real, Maria Carmen Redondo-López, Álvaro Santos Ortega, Juan A García-Arnés, Mario Gutiérrez Bedmar, Carmen Alba-Linero, Natalia García-Casares

    Background: Mild cognitive impairment (MCI) is an intermediate stage between normal aging and Alzheimer's disease (AD). Diabetes mellitus (DM) increases the risk of cognitive decline and may accelerate progression to AD. Retinal changes observed through non-invasive imaging techniques could reflect early neurodegenerative processes. Objective: To compare the influence of DM on cognitive impairment and its possible association with AD-related changes by evaluating retinal structural and vascular alterations in MCI patients, and their relationship with neuropsychological performance. Methods: A cross-sectional study of association between neuropsychological and ophthalmological variables was carried out on a sample of 40 patients divided into two groups: 20 MCI patients and 20 DM-MCI patients. Results: A decrease in the ganglion cell layer (GCL) and foveal avascular zone (FAZ) with increased arteriolar thickness at the papilla exit and superficial capillary plexus (SCP) has been demonstrated in DM-MCI patients compared to those with MCI. In the DM-MCI group, decreased GCL thickness and increased arteriolar thickness correlate with memory impairment. On the other hand, in the MCI group an increase in FAZ area and SCP show greater memory impairment, while an increase in arteriolar thickness correlates with greater executive function impairment. Conclusions: DM and MCI influence the development of retinal damage that could predict the development of AD as they maintain correlation with the impairment of cognitive domains assessed by different neuropsychological tests. Retinal neurovascular changes assessed by optical coherence tomography angiography may be informative of early cerebral alterations in MCI.

  • Open Access

    Treatment of orbital lymphatic malformation with oral sirolimus: a case report

    by Carmen Alba-Linero, María García-Lorente, Rahul Rachwani-Anil, Guillermo Luque-Aranda, María-Isabel Pérez-Cabeza, Julia Escudero

    It is estimated that lymphatic malformations in children account for 6% of all benign vascular malformations. New medical therapies have been developed for the management of lymphatic orbital disease. The purpose of this article was to describe a clinical case of orbital venolymphatic malformation in a 10-year-old boy, causing proptosis and palpebral edema. The lesion was initially treated with local sclerotherapy. However, the lesion relapsed, and was successfully treated with oral sirolimus. Prospective studies are warranted to determine the appropriate dose and extend the indications of sirolimus in these patients.


  • Open Access

    Ocular surface toxicity of depatuxizumab mafoditin (ABT-414): case reports

    by Carlos Rocha-De-Lossada, Carmen Alba Linero, Álvaro Santos Ortega, Marina Rodríguez Calvo-De-Mora, Rahul Rachwani, Davide Borroni, Emilio Alba, Manuel Benavides Orgaz, Vito Romano

    The purpose of this study is to report the clinical features and outcomes of ocular surface toxicity following depatuxizumab mafoditin (ABT-414) therapy for unresectable glioblastoma. Ocular signs and symptoms of three patients treated with ABT-414 during a phase III trial for glioblastoma multiforme were evaluated. Both eyes of all patients were damaged during the week after the first infusion of the ABT-414 molecule. In all patients, mild-to-moderate keratitis could be ascertained, along with decreased visual acuity and blurred vision, as well as foreign-body sensation and redness. Symptoms and visual acuity improved 4 weeks. In conclusion, ABT-414 therapy may cause transient ocular surface toxicity. The initiation of artificial tears and lubricant ointment was enough to control the ocular surface signs and symptoms. A multidisciplinary approach, complete ophthalmologic monitorization, and elaboration of protocols are required to adequately manage these patients.


  • Anterior segment involvement in Epstein–Barr virus: a review

    by Carmen Alba‐Linero, Carlos Rocha‐De‐Lossada, Rahul Rachwani‐Anil, Maite Sainz‐De‐La‐Maza, Gabriel Sena‐Corrales, Vito Romano, Marina Rodríguez‐Calvo‐De‐Mora

    The aim of this study is to describe the involvement of Epstein–Barr Virus (EBV) in the diseases of the ocular anterior segment. This is a narrative review designed using the PUBMED, SCOPE and Web of Science databases, searching for reported literature on findings in the anterior ocular segment related to EBV between 1990 and 2020. Epstein–Barr Virus (EBV) is implicated in the development of salmon‐coloured conjunctival masses in the context of acute mononucleosis and lymphoproliferative disorders. Moreover, EBV can cause haemorrhagic conjunctivitis and its corneal implications appear as different types of keratitis patterns. The involvement of EBV in the pathogenesis of anterior segment inflammation is not well‐defined. Current evidence regarding anterior segment disease caused by EBV infection has been proved by positive viral detection through polymerase chain reaction test in eyes with lymphoproliferative disorders known to be caused by EBV, as B‐ and NK/T‐cell lymphoid tumours. Antiviral treatment (oral Aciclovir or Valaciclovir) in anterior segment disease caused by EBV remains controversial.


  • Ocular side effects of checkpoint inhibitors

    by Carmen Alba-Linero, Emilio Alba


  • Autologous versus allogeneic versus umbilical cord sera for the treatment of severe dry eye disease: a double‐blind randomized clinical trial

    by Marina Rodríguez Calvo‐De‐Mora, Cayetano Domínguez‐Ruiz, Francisco Barrero‐Sojo, Gustavo Rodríguez‐Moreno, Cristina Antúnez Rodríguez, Laura Ponce Verdugo, María del Carmen Hernández Lamas, Luisa Hernández‐Guijarro, Jacinto Villalvilla Castillo, Idefonso Fernández‐Baca Casares, et al.

    Purpose: To measure the effects of Autologous serum (AS), Allogeneic Serum (HS) and Umbilical Cord serum (CS) eye drops in severe dry eye disease (DES), as well as to characterize and quantify several molecules in the three sera (albumin, fibronectin; Vitamin A and E; IgG, IgA and IgM; Transforming growth factor β; Epithelial growth factor).Methods: Randomized, double‐blind, single‐centre, three‐arm (AS, HS and CS) clinical trial. Sixty‐three subjects were included with severe DES, 21 in each arm of the study. Visual acuity, Schirmer test, Breakup time (BUT), lissamine green, fluorescein staining measurements and a questionnaire were performed prior to treatment, and after one‐month and three‐month follow‐up.Results: There was a significant main effect of time on visual acuities, Schirmer and BUT tests and fluorescein and lissamine green staining measurements and questionnaire scores (p = 0.015, p = 0.002, p < 0.001, p < 0.001, p = 0.031 and p < 0.001, respectively), although there was no significant interaction between time and serum type, nor between serum type and the test performed. Regarding the concentration of molecules, in our study AS contained significantly higher concentrations of IgA, IgG and fibronectin whereas HS contained significantly higher concentration of IgM, vitamins A and E, TGF and albumin. Contrary to previous reports, CS did not show higher concentration of any of the molecules analysed.Conclusions and relevance: The three sera were effective in the treatment of severe DES. CS did not contain a higher proportion of molecules compared to AS/HS. More research is needed to assess the effect of AS in patients with DES and autoimmune diseases.


  • MULTI-MODAL IMAGING IN DIFFUSE SUBRETINAL FIBROSIS WITH UVEITIS SYNDROME

    by Aina M.D Moll-Udina, Carmen M.D. Alba-Linero, Victor M.D. Llorenç, Alfredo M.D. Adán

    Purpose: To describe clinical features including multimodal imaging in a case of diffuse subretinal fibrosis and uveitis syndrome. Methods: A young patient presented with counting fingers in both eyes due to posterior uveitis and unresponsive to systemic corticosteroids. Ultra-wide field pseudo-color and autofluorescence imaging, optical coherence tomography angiography (OCT-A), en-face OCT-A, and spectral-domain optical coherence were performed. Results: Clinical examination revealed a bilateral fibrosis plaque in both fovea and macular multifocal choroidal lesions associated, with no vitritis. Ultra-wide field-autofluorescence allowed us to determine activity showing a hyperfluorescent pattern. En-face OCT-A at the level of the ellipsoid layer showed multiple hyperreflective lesions surrounding a hyperreflective fibrosis plaque in both eyes, which improved and stabilized during the follow-up. Optical coherence tomography angiography at the level of retina pigmentary epithelium-choriocapillaris revealed neocapillary network changes along the chronification of the disease. The patient required the addition of intravitreal dexamethasone implants (Ozurdex) to control the acute rebounds and anti-TNFα to control the underlying inflammatory process. Conclusion: This is the first diffuse subretinal fibrosis with uveitis syndrome reported with a complete En-face OCT-A and OCT-A examination. This multi-modal imaging will improve the monitoring of the disease's activity and the chronicity changes.